SENORES PHARMACEUTICALS L (SENORES) Share Price Rises 5.04% Today

SENORES Share Price is trading at Rs 1,499, up 5.04% from the previous close, with market capitalisation at Rs 6,572.31 Cr as of 07 September 2026 at 3:22:48 PM IST. The move places SENORES among the day’s notable gainers in the Indian stock market, even though the latest Univest data confirms the price event without establishing a company-specific catalyst. That makes the stock relevant for investors tracking SENORES Share Price Today, especially because the move comes alongside a valuation profile that is richer than the broader healthcare industry median. Univest sees this as a classic price-action event where the current move, market cap and fundamentals deserve attention together.

The stock opened at Rs 1,435.50, touched a high of Rs 1,499 and a low of Rs 1,418.85. The gap between the previous close of Rs 1,427.10 and the latest traded price reflects fresh interest in SENORES Stock News, while turnover of Rs 5.12 Cr shows active market participation in a relatively small-cap healthcare name. For readers searching SENORES Share Price Live or SENORES Stock News Today, the key point is simple: the session is marked by a share price rise, but the verified numbers do not point to a separate trigger.

SENORES Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,499
Previous Close	Rs 1,427.1
Today's Move	Rs 71.9 (+5.04%)
Open	Rs 1,435.5
High	Rs 1,499
Low	Rs 1,418.85
Turnover	Rs 5.12 crore
Market Capitalisation	Rs 6,572.31 crore
Market Cap Category	Mid Cap

SENORES PHARMACEUTICALS L (SENORES) rose to Rs 1,499 from the previous close of Rs 1,427.1, a move of Rs 71.9 or 5.04%. The stock opened at Rs 1,435.5, reached a high of Rs 1,499, recorded a low of Rs 1,418.85.

SENORES Share Price Today is up by Rs 71.90 and has risen 5.04% from the previous close. The stock traded between Rs 1,418.85 and Rs 1,499, and the latest price sits at the day’s high. That price action places SENORES in the Stocks in News category for the healthcare space, with the move reflecting a positive shift in sentiment during Share Market Today. Univest tracks such moves as part of broader Market Movers and Stock Updates, but the confirmed numbers here only establish the rise, not the reason behind it. For traders following SENORES Share Price Update, the main development is the firm trade above the previous close and near the top of the day’s range.

SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,572.31 crore
P/E Ratio	52.01x
P/B Ratio	6.82x
ROE	14.14%
ROCE	15.66%
EPS	Rs 27.44
Book Value Per Share	Rs 209.27
Dividend Yield	0%

SENORES PHARMACEUTICALS L (SENORES) fundamental metrics show P/E 52.01x, P/B 6.82x, ROE 14.14%, ROCE 15.66%. These figures provide context only and are not a buy or sell signal.

SENORES PHARMACEUTICALS L has a market capitalisation of Rs 6572.31 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 52.01x, P/B at 6.82x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.14% and ROCE of 15.66%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 27.44, book value per share of Rs 209.27, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.83x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	52.01x
Benchmark Median P/E	32.83x
Benchmark Average P/E	48.79x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	6.82x
Benchmark Median P/B	2.92x
Company ROE	14.14%
Benchmark Median ROE	11.78%
Company ROCE	15.66%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 6,572.31 crore
Benchmark Median Market Cap	Rs 674.09 crore

SENORES PHARMACEUTICALS L (SENORES) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 52.01x, which is above the benchmark median of 32.83x, a difference of +58.42%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SENORES PHARMACEUTICALS L (SENORES) has a ROE of 14.14%, which is above the benchmark median of 11.78%, a difference of +20.03%. SENORES PHARMACEUTICALS L (SENORES) has a ROCE of 15.66%, which is above the benchmark median of 13.65%, a difference of +14.73%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.67	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	82.59	13.68	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	84.58	20.55	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.19	3.18	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	24.78	4.15	19.69	21.39

SENORES PHARMACEUTICALS L (SENORES) has a P/E ratio of 52.01x compared with the displayed peer median of 37.67x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.14% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.66% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. SENORES PHARMACEUTICALS L (SENORES) has a market capitalisation of Rs 6,572.31 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching SENORES

• SENORES Share Price rose 5.04% to Rs 1,499, placing it among the day’s notable healthcare movers.
• The latest price is at the day’s high, while the previous close of Rs 1,427.10 shows a clear gap in price action.
• P/E of 52.01 and P/B of 6.82 keep SENORES Share Price under valuation scrutiny.
• ROE of 14.14% and ROCE of 15.66% give the SENORES Fundamental Analysis story some support.
• Sector and peer comparisons show SENORES in a richer valuation band than several listed healthcare names.

About SENORES PHARMACEUTICALS L

SENORES PHARMACEUTICALS L operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is followed on both NSE and BSE, and its market position is shaped by a mix of valuation, profitability and sector sentiment rather than by a pure size story. With a market cap of Rs 6,572.31 Cr, it is much smaller than the large-cap leaders in the pharmaceutical pack, yet it still draws attention because its share price is sensitive to investor interest and relative valuation.

For readers tracking SENORES Company News, the business context matters because pharmaceutical names often trade on a blend of earnings quality, return ratios and industry comparisons. SENORES Share Price News therefore needs to be read alongside broader healthcare benchmarks, peer multiples and the company’s own earnings metrics. That is the most practical way to interpret a stock like SENORES on Univest, especially when the session is being driven by price action rather than a stated event.

Frequently Asked Questions

Why is SENORES Share Price rising today?

Ans. SENORES Share Price is up 5.04% to Rs 1,499, but the latest Univest data confirms the move without identifying a company-specific catalyst. The rise is visible in today’s price action and market cap.

What is the current SENORES Share Price Today?

Ans. SENORES Share Price Today is Rs 1,499, which is Rs 71.90 above the previous close of Rs 1,427.10. The stock also touched a high of Rs 1,499 during the trade.

What is the market capitalisation of SENORES?

Ans. SENORES has a market capitalisation of Rs 6,572.31 Cr. That places it well above the industry median in Pharmaceuticals & Drugs, while still far below the largest healthcare companies.

Is SENORES expensive based on valuation?

Ans. SENORES trades at a P/E of 52.01 and a P/B of 6.82. Both are above the industry median, so the stock is priced richer than many healthcare peers on the latest Univest figures.

How do SENORES ROE and ROCE look?

Ans. SENORES reports ROE of 14.14% and ROCE of 15.66%. Both are above the industry median, which suggests the business is generating reasonable returns relative to equity and capital employed.

What do EPS and book value show for SENORES Share Price?

Ans. EPS stands at 27.44 and book value is 209.27. EPS reflects earnings per share, while book value shows accounting net worth per share, helping explain the current SENORES Share Price.

Does SENORES pay a dividend?

Ans. Dividend yield is 0, so the current investment case is not based on payout income. Investors tracking SENORES Share Price are likely to focus more on earnings, returns and valuation.

How does SENORES compare with healthcare peers?

Its valuation is higher than several peers, so comparison matters.

Track SENORES Share Price on Univest

Use SENORES PHARMACEUTICALS L (SENORES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track SENORES Share Price on Univest for live price updates, company news, financial ratios, market cap, EPS, book value, dividend yield, 52-week levels and sector context. Univest also helps users review SENORES Stock Analysis, SENORES Fundamental Analysis and SENORES Share Price Today in one place.